270
Participants
Start Date
March 27, 2014
Primary Completion Date
March 22, 2016
Study Completion Date
March 22, 2016
QGE031
QGE031 120 mg/mL solution for subcutaneous injection
Novartis Investigative Site, Budapest
Novartis Investigative Site, Törökbálint
Novartis Investigative Site, San Miguel de Tucumán
Novartis Investigative Site, Berea
Novartis Investigative Site, Mar del Plata
Novartis Investigative Site, Pécs
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bucheon-si
Novartis Investigative Site, Rudersdorf
Novartis Investigative Site, Suwon
Novartis Investigative Site, Milan
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Turku
Novartis Investigative Site, Waldorf
Novartis Investigative Site, Fairfax
Novartis Investigative Site, Cheongju-si
Novartis Investigative Site, Mersin
Novartis Investigative Site, Tampere
Novartis Investigative Site, Montpellier
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Izmir
Novartis Investigative Site, Padua
Novartis Investigative Site, Verona
Novartis Investigative Site, Owensboro
Novartis Investigative Site, Guadalajara
Novartis Investigative Site, Evansville
Novartis Investigative Site, Petah Tikva
Novartis Investigative Site, Mainz
Novartis Investigative Site, Minneapolis
Novartis Investigative Site, Pisa
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Jerusalem
Novartis Investigative Site, Le Kremlin
Novartis Investigative Site, Prievidza
Novartis Investigative Site, Messina
Novartis Investigative Site, Yaroslavl
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Ryazan
Novartis Investigative Site, Cluj-Napoca
Novartis Investigative Site, Brasov
Novartis Investigative Site, Brasov
Novartis Investigative Site, Nizhny Novgorod
Novartis Investigative Site, Barnaul
Novartis Investigative Site, Kfar Saba
Novartis Investigative Site, Rehovot
Novartis Investigative Site, Jerusalem
Novartis Investigative Site, CABA
Novartis Investigative Site, CABA
Novartis Investigative Site, CABA
Novartis Investigative Site, Santa Fe
Novartis Investigative Site, Rosario
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Mendoza
Novartis Investigative Site, Mendoza
Novartis Investigative Site, Santa Fe
Novartis Investigative Site, Ottawa
Novartis Investigative Site, Montreal
Novartis Investigative Site, Québec
Novartis Investigative Site, Trutnov
Novartis Investigative Site, Teplice
Novartis Investigative Site, Brno
Novartis Investigative Site, Břeclav
Novartis Investigative Site, Tábor
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Bialystok
Novartis Investigative Site, Lodz
Novartis Investigative Site, Coimbra
Novartis Investigative Site, Lisbon
Novartis Investigative Site, Porto
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Nitra
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Košice
Novartis Investigative Site, Ružomberok
Novartis Investigative Site, Seoul
Novartis Investigative Site, Gwangju
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Bradford
Novartis Investigative Site, Southampton
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY